Skip to main content
SpringerLink
Log in

Drug-eluting stents in renal artery stenosis

  • Interventional
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Because of higher acute and long-term success rates compared with balloon angioplasty alone, percutaneous stent implantation has become an accepted therapy for the treatment of atherosclerotic renal artery stenosis. Restenosis rates after successful renal stent placement vary from 6 up to 40%, depending on the definition of restenosis, the diameter of the treated vessel segment and comorbidities. The safety and efficacy of drug-eluting stents for the treatment of renal-artery stenosis is poorly defined. The recently published GREAT study is the only prospective study, comparing bare-metal and sirolimus-coated low profile stent systems in renal artery stenosis, showing a relative risk reduction of angiographic binary in-stent restenosis by 50%. This is an opinion paper on indications, current treatment options and restenosis rates following renal artery stenting and the potential use of drug-eluting stents for this indication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Missouris CG, Buckenham T, Cappuccio FP et al (1994) Renal artery stenosis : a common and important problem in patients with peripheral vascular disease. Am J Med 96:10–14

    Article  PubMed  CAS  Google Scholar 

  2. Gross CM, Krämer J, Waigand J et al (1998) Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn 45:1–8

    Article  PubMed  CAS  Google Scholar 

  3. Tollefson DFJ, Ernst CB (1991) Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vasc Surg 14:327–331

    Article  PubMed  CAS  Google Scholar 

  4. Zierler RE, Bergelin RO, Davidson RC et al (1996) A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens 9:1055–1061

    Article  PubMed  CAS  Google Scholar 

  5. Geyskes GG (1988) Treatment of renovascular hypertension with percutaneous transluminal renal angioplasty. Am J Kidney Dis 12:253–265

    PubMed  CAS  Google Scholar 

  6. Ramsay LE, Waller PC (1990) Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. BMJ 300:569–572

    Article  PubMed  CAS  Google Scholar 

  7. Rees CR, Palmaz JC, Becker GJ et al (1991) Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: preliminary report of a multicenter study. Radiology 181:507–514

    PubMed  CAS  Google Scholar 

  8. Harden PN, MacLeod MJ, Rodger RSC et al (1997) Effect of renal artery stenting on progression of renovascular renal failure. Lancet 349:1133–1136

    Article  PubMed  CAS  Google Scholar 

  9. Grüntzig A, Kuhlmann U, Vetter W et al (1978) Treatment of renovascular hypertension with percutaneous transluminal dilatation of renal artery stenosis. Lancet 1:801–802

    Article  PubMed  Google Scholar 

  10. Hoffmann O, Carreres T, Sapoval MR et al (1998) Ostial renal artery stenosis angioplasty: immediate and mid-term angiographic and clinical results. J Vasc Interv Radiol 9:65–73

    Article  Google Scholar 

  11. Grim CE, Luft FC, Yune HY et al (1981) Percutaneous transluminal dilatation in the treatment of renal vascular hypertension. Ann Intern Med 95:439–442

    PubMed  CAS  Google Scholar 

  12. Baert AL, Wilms G, Amery A et al (1990) Percutaneous transluminal renal angioplasty: Initial results and long-term follow-up in 202 patients. Cardiovasc Intervent Radiol 13:22–28

    Article  PubMed  CAS  Google Scholar 

  13. Leertouwer TC, Gussenhoven EJ, Bosch JL et al (2000) Stent placement for renal arterial stenosis: where do we stand. A meta-analysis. Radiology 216:78–85

    PubMed  CAS  Google Scholar 

  14. Plouin PF (2003) Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management. Am J Kidney Dis 42:851–857

    Article  PubMed  Google Scholar 

  15. Losito A, Errico R, Santirosi P et al (2005) Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant 20:1604–1609

    Article  PubMed  CAS  Google Scholar 

  16. van de Ven PJ, Kaatee R, Beutler JJ et al (1999) Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomized trial. Lancet 353:282–286

    Article  PubMed  Google Scholar 

  17. Schillinger M, Minar E, Ahmadi R (2004) Treating renal artery stenosis. A statement pro endovascular therapy. Herz 29:68–75

    Article  PubMed  Google Scholar 

  18. Nolan BW, Schermerhorn ML, Powell RJ et al (2005) Outcomes of renal artery angioplasty and stenting using low-profile systems. J Vasc Surg 41:46–52

    Article  PubMed  Google Scholar 

  19. Sapoval M, Zähringer M, Pattynama P et al (2005) Low-profile stent system for treatment of atherosclerotic renal artery stenosis: The GREAT trial. J Vasc Interv Radiol 16:1195–1202

    PubMed  Google Scholar 

  20. Zeller T, Rastan A, Kliem M et al (2005) Impact of carbon coating on the restenosis rate after stenting of atherosclerotic renal artery stenosis. J Endovasc Ther 12:605–611

    Article  PubMed  Google Scholar 

  21. Nolan BW, Schermerhorn ML, Powell RJ et al (2005) Restenosis in gold-coated renal artery stents. J Vasc Surg 42:40–46

    Article  PubMed  Google Scholar 

  22. Morice MC, Serruys PW, Sousa JE et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780

    Article  PubMed  CAS  Google Scholar 

  23. Moses JW, Leon MB, Popma JJ et al (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323

    Article  PubMed  CAS  Google Scholar 

  24. Duda Sh, Poerner TC, Wiesinger B et al (2003) Drug-eluting stents: potential applications for peripheral arterial occlusive disease. J Vasc Interv Radiol 14:291–301

    PubMed  Google Scholar 

  25. Toutouzas K, Di Mario C, Falotico R et al (2002) Sirolimus-eluting stents: a review of experimental and clinical findings. Z Kardiol 91:49–57

    Article  PubMed  CAS  Google Scholar 

  26. Stone GW, Ellis SG, Cox DA (2004) One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 109:1942–1947

    Article  PubMed  CAS  Google Scholar 

  27. Zähringer M, Sapoval M, Pattynama PMT et al (2007) Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT trial): angiographic follow-up after 6 month and clinical outcome up to 2 years. J Endovasc Ther 14:460–468

    Article  PubMed  Google Scholar 

  28. Zeller T, Müller C, Frank U et al (2003) Gold coating and restenosis after primary stenting of ostial renal artery stenosis. Catheter Cardiovasc Interv 60:1–6

    Article  PubMed  Google Scholar 

  29. Sacks D, Marinelli DL, Martin LG et al (1997) Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. Technology Assessment Committee. J Vasc Interv Radiol 8:137–149

    PubMed  CAS  Google Scholar 

  30. Lederman RJ, Mendelsohn FO, Santos R et al (2001) Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 142:314–323

    Article  PubMed  CAS  Google Scholar 

  31. Bax L, Mali WP, Van De Ven PJ et al (2002) Repeated intervention for in-stent restenosis of the renal arteries. J Vasc Interv Radiol 13:1219–1224

    Article  PubMed  Google Scholar 

  32. Otah KE, Alhaddad IA (2004) Intravascular ultrasound-guided cutting balloon angioplasty for renal artery stent restenosis. Clin Cardiol 27:581–583

    Article  PubMed  Google Scholar 

  33. Neumann FJ, Desmet W, Grube E et al (2005) Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 111:2107–2111

    Article  PubMed  CAS  Google Scholar 

  34. Kakkar AK, Fischi M, Narins CR (2006) Drug-eluting stent implantation for treatment of recurrent renal artery in-stent restenosis. Catheter Cardiovasc Interv 68:118–122

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands

    P. M. T. Pattynama

  2. genae associates nv, Antwerp, Belgium

    A. Talen

  3. Service de Radiologie Cardio-Vasculaire, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75015, Paris, France

    M. Sapoval

  4. Inserm U 780 epidémiologie Cardio Vasculaire, Paris, France

    M. Sapoval

  5. Department of Radiology, Marienhospital Stuttgart, Böheimstr. 37, 70199, Stuttgart, Germany

    M. Zähringer

Authors
  1. M. Zähringer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. M. T. Pattynama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Talen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Sapoval
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Zähringer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zähringer, M., Pattynama, P.M.T., Talen, A. et al. Drug-eluting stents in renal artery stenosis. Eur Radiol 18, 678–682 (2008). https://doi.org/10.1007/s00330-007-0789-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-007-0789-5

Keywords

Search

Navigation